Marshall Wace, LLP Takeda Pharmaceutical CO LTD Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $693,511 - $781,090	-41,904 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $721,604 - $859,361	-43,184 Reduced 50.75%	41,904 $765,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $353,046 - $435,171	-22,940 Reduced 21.24%	85,088 $1.55 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $1.69 Million - $1.89 Million	-98,724 Reduced 47.75%	108,028 $1.93 Million
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $1.78 Million - $2.37 Million	121,664 Added 142.99%	206,752 $3.71 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $1.39 Million - $2.17 Million	-106,791 Reduced 55.66%	85,088 $1.29 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $31.5 Million - $38.9 Million	-1,867,849 Reduced 90.68%	191,879 $3.79 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $312,373 - $347,962	-19,342 Reduced 0.93%	2,059,728 $35.4 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $14.7 Million - $18.1 Million	-885,137 Reduced 29.86%	2,079,070 $36.8 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $49.5 Million - $63.8 Million	2,964,207 New	2,964,207 $60.4 Million

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.